The goal of this proposed project is to evaluate the feasibility and preliminary effect
of metacognitive strategy training to improve activity performance, cognition, and
quality of life in breast cancer survivors with cancer-related cognitive impairment
(CRCI). The other goal of this proposed project is to examine the effects of CO-OP on
resting (rsFC)- and task-state functional connectivity as compared to an inactive control
group.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06545045.
Locations matching your search criteria
United States
Missouri
Columbia
MU Health - University Hospital/Ellis Fischel Cancer CenterStatus: Active
Contact: Anna E. Boone
Phone: 573-882-7023
Breast cancer survivors often self-report cognitive deficits, primarily in executive
functioning (planning, problem solving, multitasking), memory, and processing speed after
cancer treatment, i.e., cancer-related cognitive impairment (CRCI). The prevalence of
CRCI following breast cancer is as high as 78% and can persist chronically after
treatment has ended. In other health conditions associated with cognitive impairment,
such as traumatic brain injury, the only evidence-based recommended practice standard for
deficits in executive function is metacognitive strategy training (MCST). In this
approach, participants are taught a general cognitive strategy that can be applied in
known and novel contexts to devise task specific strategies to successfully engage in an
activity. While the cognitive deficits identified in and described by breast cancer
survivors seem quite amenable to MCST, there is no study in the published literature
which measures the efficacy of MCST on CRCI. The Cognitive Orientation to daily
Occupational Performance (CO-OP) approach is a MCST intervention in which subjects are
taught a general cognitive strategy that can be applied in known and novel contexts to
devise task specific strategies to engage in an activity. Preliminary data suggest that
CO-OP may have a positive impact on subjective and objective cognitive performance in
breast cancer survivors with CRCI. Further, this study will evaluate the
neurophysiological underpinnings associated with treatment changes through the use of
neuroimaging methods.
Trial PhaseNo phase specified
Trial Typetreatment
Lead OrganizationMU Health - University Hospital/Ellis Fischel Cancer Center
Principal InvestigatorAnna E. Boone